Teva Announces European Medicines Agency (EMA) Confirms Successful Validation … – MarketWatch

Teva Announces European Medicines Agency (EMA) Confirms Successful Validation
MarketWatch
“Uncontrolled asthma remains a serious challenge for patients and healthcare professionals despite the availability of standard of care treatment,” said Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical

and more »

View full post on asthma – Google News

Validation Of A Questionnaire Against Clinical Assessment In The Diagnosis Of Asthma In Schoolchildren.

Related Articles

Validation Of A Questionnaire Against Clinical Assessment In The Diagnosis Of Asthma In Schoolchildren.

J Asthma. 2014 Sep 18;:1-25

Authors: Hansen TE, Evjenth B, Holt J

Abstract
Abstract Aim: A questionnaire has been used repeatedly in cross sectional studies to determine the prevalence of asthma, allergic rhinoconjunctivitis (AR) and eczema among schoolchildren in Nordland County, Norway. The current study was designed to validate the questionnaire against clinical assessment as the diagnostic gold standard and to investigate the extent of possible misclassification. Methods: A subsample of 801 schoolchildren of 4150, whose parents had answered a questionnaire covering asthma and atopic diseases, underwent a detailed clinical evaluation including a standardized interview, a clinical examination, skin prick tests (SPT), blood samples, spirometry an exercise treadmill test (EIB test) and measurement of exhaled nitrogen oxide (FeNO). Results: The questionnaire had a sensitivity of 0.96 and a specificity of 0.87 for the diagnosis of asthma ever compared to clinical assessment. The overall agreement (kappa) was 0.80. After clinical assessment the prevalence of asthma ever was adjusted from 17.6 % to 16.9 % (95% CI: 15.8-18.0). The most sensitive and specific questions in identifying asthmatic children by the questionnaire were questions asking about diagnosis (‘Has the child ever had asthma?’) rather than those covering asthma symptoms such as wheeze, shortness of breath and/or cough. A positive exercise test increased the posttest probability for the asthma diagnosis only to a minimal degree. Conclusion: Based on the good agreement between the questionnaire responses and the clinical assessments, it is concluded that the questionnaire had good validity and served as a useful epidemiological tool. Detailed clinical testing added little additional information.

PMID: 25233047 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Validation of Proteomic Analyses for Allergic Asthma and Rhinitis

Conditions:   Rhinitis, Allergic;   Asthma, Allergic
Interventions:   Biological: Classification as “asthmatic” or “rhinitis only” via proteomic analysis;   Biological: Classification as “asthmatic” or “rhinitis only” according to a metacholine test
Sponsor:   Centre Hospitalier Universitaire de N?mes
Recruiting – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days